InChI=1S/C20H32O5/c1- 2- 3- 8- 14- 18(22) 19(23) 15- 10- 7- 5- 4- 6- 9- 12- 17(21) 13- 11- 16- 20(24) 25/h4- 7,9- 10,12,15,17- 19,21- 23H,2- 3,8,11,13- 14,16H2,1H3,(H,24,25) /b6- 4- ,7- 5+,12- 9+,15- 10+/t17- ,18+,19- /m1/s1 |
UXVRTOKOJOMENI-WLPVFMORSA-N |
CCCCC[C@H](O)[C@H](O)\C=C\C=C\C=C/C=C/[C@@H](O)CCCC(O)=O |
|
Homo sapiens
(NCBI:txid9606)
|
See:
DOI
|
Bronsted acid
A molecular entity capable of donating a hydron to an acceptor (Bronsted base).
(via oxoacid )
|
|
human metabolite
Any mammalian metabolite produced during a metabolic reaction in humans (Homo sapiens).
specialised pro-resolving mediator
A class of cell signaling molecules enzymatically derived from n-3 long chain polyunsaturated fatty acids that have important roles in orchestrating the resolution of tissue inflammation.
(via lipoxin )
|
|
specialised pro-resolving mediator
A class of cell signaling molecules enzymatically derived from n-3 long chain polyunsaturated fatty acids that have important roles in orchestrating the resolution of tissue inflammation.
(via lipoxin )
|
|
View more via ChEBI Ontology
(5S,6E,8Z,10E,12E,14R,15S)- 5,14,15- trihydroxyicosa- 6,8,10,12- tetraenoic acid
|
(5S,14R,6E,8Z,10E,12E,15S)- 5,14,15- trihydroxy- 6,8,10,12- eicosatetraenoic acid
|
ChEBI
|
(5S,6E,8Z,10E,12E,14R,15S)- 5,14,15- trihydroxyeicosa- 6,8,10,12- tetraenoic acid
|
ChEBI
|
(6E,8Z,10E,12E)-(5S,14R,15S)-Trihydroxyicosa-6,8,10,12-tetraenoic acid
|
KEGG COMPOUND
|
5(S),14(R)-lipoxin B4
|
ChEBI
|
5,14,15-Thet
|
ChemIDplus
|
5S,14R,15S-6,10,12-trans-8-cis-triHETE
|
ChEBI
|
5S,14R,15S-8-cis-lipoxin B
|
ChEBI
|
5S,14R,15S-Trihydroxy-6E,8Z,10E,12E-eicosatetraenoic acid
|
KEGG COMPOUND
|
Lipoxin B4
|
KEGG COMPOUND
|
LipoxinB4
|
LIPID MAPS
|
LXB4
|
KEGG COMPOUND
|
LXB4
|
ChEBI
|
4707370
|
Reaxys Registry Number
|
Reaxys
|
92950-25-9
|
CAS Registry Number
|
ChemIDplus
|
8690917
|
PubMed citation
|
Europe PMC
|
9535221
|
PubMed citation
|
Europe PMC
|
|